SCHEMBL11910910

SCHEMBL11910910

COCCNC(=O)C1=CCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 7/20 0.47
▸ HTT P42858 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ CTSK P43235 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ THRB P10828 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA13 Q8N1Q1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13185234 0.81 POLB (0.45) HPGDHTTALDH1A1KMT2ACTSK
SCHEMBL11910893 0.80 SMN1; SMN2 (0.46) HPGDALDH1A1KMT2AMEN1CTSK
SCHEMBL2523214 0.78 KDM4E (0.49) ALDH1A1MAPK1KMT2AMEN1CTSK
SCHEMBL9567550 0.74 — —
SCHEMBL9250163 0.74 HPGD (0.50) HPGDHTTALDH1A1KMT2AMEN1
SCHEMBL16087965 0.72 KMT2A (0.65) HPGDALDH1A1MAPK1KMT2AMEN1
SCHEMBL13165470 0.72 CTSK (0.44) ALDH1A1CTSK
SCHEMBL13270445 0.70 HPGD (0.41) HPGDHTTALDH1A1MAPK1KMT2A
SCHEMBL11910909 0.70 PTPRC (0.44) CTSKMAPTL3MBTL1
SCHEMBL30465000 0.70 CTSK (0.52) HPGDHTTALDH1A1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232360-B2 Stereoregular ROMP polymers RESEARCH FOUNDATION OF STATE UNIVERSITY OF N.Y. (US) 2012-07-31 — — US disclosed
US-8232360-B2 Stereoregular ROMP polymers RESEARCH FOUNDATION OF STATE UNIVERSITY OF N.Y. (US) 2012-07-31 — — US disclosed
US-20110251363-A1 STEREOREGULAR ROMP POLYMERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-10-13 — — US disclosed
US-20110251363-A1 STEREOREGULAR ROMP POLYMERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-10-13 — — US disclosed
WO-2008019217-A2 STEREOREGULAR ROMP POLYMERS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-02-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251363-A1 STEREOREGULAR ROMP POLYMERS PCBP1, PARG, OSGEP HPGD 2989/4885HTT 710/4885ALDH1A1 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback